Synthesis and antimicrobial properties of substituted 3-aminoxypropionyl and 3-aminoxy-(E)-2-methoxyiminopropionyl...

Area of Science:

• Medicinal Chemistry
• Microbiology
• Organic Synthesis

Background:

• Aztreonam is a monocyclic beta-lactam antibiotic with activity against Gram-negative bacteria.
• Development of novel beta-lactam analogs is crucial for combating antibiotic resistance.
• Understanding structure-activity relationships guides the design of new antimicrobial agents.

Purpose of the Study:

• To synthesize novel monobactam compounds (VII and VIII) incorporating the aztreonam nucleus.
• To evaluate the in vitro antimicrobial activity of synthesized compounds against Gram-positive and Gram-negative bacteria.
• To compare the antibacterial efficacy of novel compounds with aztreonam.

Main Methods:

• Synthesis of substituted 3-aminoxyproprionyl (VII) and 3-aminoxy-(E)-2-methoxyiminopropionyl monobactams (VIII).
• Reaction of triethylammonium (3S, 4S)-3-amino-4-methyl-2-oxo-1-azetidinsulfonate with specific aminoxy acids.
• In vitro antimicrobial susceptibility testing against diverse bacterial strains, including beta-lactamase producers.

Main Results:

• Compounds VII and VIII exhibited limited antibacterial activity against Gram-positive bacteria, similar to aztreonam.
• Synthesized monobactams (VII and VIII) were found to be practically inactive against Gram-negative bacteria.
• Aztreonam demonstrated high activity against Gram-negative microorganisms, contrasting with the novel compounds.

Conclusions:

• The synthesized monobactam derivatives (VII and VIII) do not possess significant antimicrobial activity, particularly against Gram-negative bacteria.
• The structural modifications in compounds VII and VIII led to a loss of the characteristic activity profile of aztreonam.
• Further research is needed to identify beta-lactam structures with improved antibacterial efficacy.